QY211
/ E-nitiate Biopharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
May 06, 2023
A First-in-Human Study of QY211 Gel in Adult Subjects
(clinicaltrials.gov)
- P1 | N=56 | Recruiting | Sponsor: E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd.
New P1 trial • Atopic Dermatitis • Dermatitis • Dermatology • Immunology
1 to 1
Of
1
Go to page
1